Tumor-responsive AAV arms cancer cells to enhance CAR-T cell therapy in solid tumors

Chimeric antigen receptor (CAR)-T-cell therapy remains limited in solid tumors by the scarcity of suitable target antigens and an immunosuppressive tumor microenvironment. Here, we developed a tumor-responsive recombinant adeno-associated virus (rAAV) strategy that harnesses aberrant NF-κB activity to establish a shared synthetic CAR target across tumor types. Using an NF-κB-responsive decoy minimal promoter (DMP), rAAV-SA drove tumor-preferential surface expression of a synthetic antigen (SA), enabling antigen-dependent CAR-T-cell activation, degranulation, and cytotoxicity. Systemic rAAV-SA delivery combined with CAR-T cells produced antitumor activity in triple-negative breast cancer (TNBC) and colorectal cancer xenograft models. We subsequently engineered rAAV-ARMS (antigen redirection and multifunctional secreted effectors), integrating SA expression with tumor-local production of an IL-15/IL-15Rα sushi-domain fusion, CXCL10, and IFN-γ. Compared with antigen redirection alone, rAAV-ARMS enhanced CAR-T-cell-mediated killing in three-dimensional tumor spheroids and, in a TNBC xenograft model, increased intratumoral T-cell accumulation and improved the efficacy of intravenously administered CAR-T cells, without overt systemic toxicity under the conditions examined. These findings establish a tumor-programmed platform for target-redirected universal CAR-T-cell therapy in solid tumors.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.766910
Primary Topic
CAR-T cell therapy research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Tumor-responsive AAV arms cancer cells to enhance CAR-T cell therapy in solid tumors

谢杏仪, Yile Wang, Ziyan Kong, Yunqi Zhao et al.
4 links
bioRxiv (Cold Spring Harbor Laboratory)
CAR-T cell therapy research
preprint

Tumor-responsive AAV arms cancer cells to enhance CAR-T cell therapy in solid tumors

谢杏仪, Yile Wang, Ziyan Kong, Yunqi Zhao, Yongqian Shu, Xuhui Wen, Jinke Wang, Zhimin Fan, Lu Wang, Aiwei Yan
preprint en

Abstract

Chimeric antigen receptor (CAR)-T-cell therapy remains limited in solid tumors by the scarcity of suitable target antigens and an immunosuppressive tumor microenvironment. Here, we developed a tumor-responsive recombinant adeno-associated virus (rAAV) strategy that harnesses aberrant NF-κB activity to establish a shared synthetic CAR target across tumor types. Using an NF-κB-responsive decoy minimal promoter (DMP), rAAV-SA drove tumor-preferential surface expression of a synthetic antigen (SA), enabling antigen-dependent CAR-T-cell activation, degranulation, and cytotoxicity. Systemic rAAV-SA delivery combined with CAR-T cells produced antitumor activity in triple-negative breast cancer (TNBC) and colorectal cancer xenograft models. We subsequently engineered rAAV-ARMS (antigen redirection and multifunctional secreted effectors), integrating SA expression with tumor-local production of an IL-15/IL-15Rα sushi-domain fusion, CXCL10, and IFN-γ. Compared with antigen redirection alone, rAAV-ARMS enhanced CAR-T-cell-mediated killing in three-dimensional tumor spheroids and, in a TNBC xenograft model, increased intratumoral T-cell accumulation and improved the efficacy of intravenously administered CAR-T cells, without overt systemic toxicity under the conditions examined. These findings establish a tumor-programmed platform for target-redirected universal CAR-T-cell therapy in solid tumors.

bioRxiv (Cold Spring Harbor Laboratory)
Nanjing University of Chinese Medicine (CN), Nanjing Traditional Chinese Medicine Hospital (CN), Jiangsu Province Hospital (CN), Southeast University (CN)
National Natural Science Foundation of China
Good health and well-being
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon